EXHIBIT 23.1
Published on October 8, 2024
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated June 21, 2024, with respect to the consolidated financial statements of Acasti Pharma Inc., incorporated
herein by reference, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
|
|
Philadelphia, Pennsylvania
|
|
October 8, 2024
|